Jamie Dimon says AI is already reshaping JPMorgan Chase’s workforce as bank plans ‘huge redeployment’
JPMorgan, the world’s biggest bank by market cap, has the industry’s largest annual tech budget at nearly $20 billion, and it has outlined an ambitious AI plan.
BlackRock’s Rick Rieder is locking in attractive yields in this corner of the bond market before the opportunity slips away
BlackRock’s Rick Rieder tells CNBC where he is investing for income right now and why he thinks the opportunity may not last.
Apple to move some Mac Mini production to U.S. this year as part of effort to boost domestic manufacturing
Apple is expanding a facility in Houston as part of a $600 billion commitment to U.S. manufacturing.
Watch these chart formations for clues into what’s next for market volatility
Despite talk of the great rotation out of growth and technology and into value and defensive areas, the Nasdaq 100 is only 4.5% off its all-time high.
Cursor announces major update to AI agents as coding tool battle heats up
Cursor announced updates to its AI coding agents as the startup works to fend off competition from rivals
Microsoft and SpaceX’s Starlink partner on global community internet effort
The collaboration will help boost demand for Elon Musk’s space company, which has contracts with the Defense Department and NASA.
Bitcoin mining is no longer profitable after crypto’s latest downward turn, analyst says
Bitcoin briefly sank below $63,000 on Tuesday, dragging down its miners alongside it.
Software stocks rebound as Anthropic announces new partnerships
Cybersecurity and software names have sold off heavily in recent weeks as investors fretted about potential disruption from artificial intelligence.
Classic ‘TACO’? Investors shrug off Trump’s latest tariff announcement
Global equity markets were muted as Trump’s latest tariffs came into effect at 10%, a lower-than-expected rate.
Novo Nordisk to slash GLP-1 list prices by up to 50% in U.S. to cut costs for insured patients
The cuts aim to make the drugs more accessible to insured patients, particularly people with high-deductible health plans or coinsurance benefit designs.
